DE69839477D1 - Verfahren zum verbessern der anhäufung von radioaktiven verbindungen in gewebe - Google Patents
Verfahren zum verbessern der anhäufung von radioaktiven verbindungen in gewebeInfo
- Publication number
- DE69839477D1 DE69839477D1 DE69839477T DE69839477T DE69839477D1 DE 69839477 D1 DE69839477 D1 DE 69839477D1 DE 69839477 T DE69839477 T DE 69839477T DE 69839477 T DE69839477 T DE 69839477T DE 69839477 D1 DE69839477 D1 DE 69839477D1
- Authority
- DE
- Germany
- Prior art keywords
- compound
- radiolabeled compound
- radioligand
- administration
- life
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 4
- 230000002285 radioactive effect Effects 0.000 title 1
- 238000001802 infusion Methods 0.000 abstract 2
- 239000002287 radioligand Substances 0.000 abstract 2
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108010078791 Carrier Proteins Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 230000033077 cellular process Effects 0.000 abstract 1
- 230000004700 cellular uptake Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/121—Solutions, i.e. homogeneous liquid formulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measurement Of Radiation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97752097A | 1997-11-24 | 1997-11-24 | |
| PCT/US1998/024912 WO1999026551A1 (en) | 1997-11-24 | 1998-11-23 | Method to enhance tissue accumulation of radiolabeled compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69839477D1 true DE69839477D1 (de) | 2008-06-26 |
Family
ID=25525221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69839477T Expired - Fee Related DE69839477D1 (de) | 1997-11-24 | 1998-11-23 | Verfahren zum verbessern der anhäufung von radioaktiven verbindungen in gewebe |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0961591B1 (de) |
| JP (1) | JP2001513114A (de) |
| CN (1) | CN1250361A (de) |
| AT (1) | ATE395002T1 (de) |
| AU (1) | AU749403B2 (de) |
| CA (1) | CA2277180C (de) |
| DE (1) | DE69839477D1 (de) |
| ES (1) | ES2307325T3 (de) |
| NZ (1) | NZ336727A (de) |
| WO (1) | WO1999026551A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050124549A1 (en) | 2001-03-06 | 2005-06-09 | Uberti Ettore C.D. | Method of modulating the proliferation of medullary thyroid carcinoma cells |
| CN104491890A (zh) * | 2014-11-21 | 2015-04-08 | 北京肿瘤医院 | 放射性核素标记的新型生长抑素类似物分子探针及其应用 |
| EP3727473A4 (de) * | 2017-12-22 | 2022-07-06 | Cornell University | In pet und cerenkov-lumineszenzbildgebung nützliche, 18f-markierte peptidliganden |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9111199D0 (en) * | 1991-05-23 | 1991-07-17 | Sandoz Ltd | Improvements in or relating to organic compounds |
| HU219336B (en) * | 1989-07-20 | 2001-03-28 | Novartis Ag | Process for producing peptide derivatives and pharmaceutical compositions comprising such compounds and diagnostic unit containing such compounds |
| HUT66294A (en) * | 1993-01-12 | 1994-11-28 | Sandoz Ag | Polypeptides and process for producing them |
| US5597894A (en) * | 1995-06-05 | 1997-01-28 | The Louisiana State University Medical Center Foundation | Multi-tyrosinated somatostatin analogs |
| US6358491B1 (en) * | 1999-08-27 | 2002-03-19 | Berlex Laboratories, Inc. | Somatostatin analogs |
-
1998
- 1998-11-23 DE DE69839477T patent/DE69839477D1/de not_active Expired - Fee Related
- 1998-11-23 CN CN98803225A patent/CN1250361A/zh active Pending
- 1998-11-23 JP JP52921999A patent/JP2001513114A/ja active Pending
- 1998-11-23 WO PCT/US1998/024912 patent/WO1999026551A1/en active IP Right Grant
- 1998-11-23 NZ NZ336727A patent/NZ336727A/en unknown
- 1998-11-23 AT AT98966733T patent/ATE395002T1/de not_active IP Right Cessation
- 1998-11-23 AU AU24484/99A patent/AU749403B2/en not_active Ceased
- 1998-11-23 EP EP98966733A patent/EP0961591B1/de not_active Expired - Lifetime
- 1998-11-23 CA CA002277180A patent/CA2277180C/en not_active Expired - Fee Related
- 1998-11-23 ES ES98966733T patent/ES2307325T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999026551A1 (en) | 1999-06-03 |
| AU749403B2 (en) | 2002-06-27 |
| CA2277180A1 (en) | 1999-06-03 |
| EP0961591B1 (de) | 2008-05-14 |
| ES2307325T3 (es) | 2008-11-16 |
| NZ336727A (en) | 2001-10-26 |
| EP0961591A4 (de) | 2002-07-31 |
| ATE395002T1 (de) | 2008-05-15 |
| JP2001513114A (ja) | 2001-08-28 |
| CN1250361A (zh) | 2000-04-12 |
| EP0961591A1 (de) | 1999-12-08 |
| CA2277180C (en) | 2006-12-05 |
| AU2448499A (en) | 1999-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Order et al. | 90Yttrium antiferritin—a new therapeutic radiolabeled antibody | |
| Palmedo et al. | Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases | |
| Stolz et al. | The somatostatin receptor-targeted radiotherapeutic [90 Y-DOTA-d Phe 1, Tyr 3] octreotide (90 Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumours | |
| Wessels et al. | Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies | |
| Kukis et al. | Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates | |
| AT392004B (de) | Verfahren zur herstellung eines monoklonalen antikoerpers gegen tumor-assoziiertes antigen und dessen verwendung | |
| CA2034484C (en) | Radioimmunotherapy using .alpha.-particles emission | |
| WO2004096293A3 (en) | Method and device for radiotherapy | |
| DE69635080D1 (de) | Radiometall-bindende analoge von lhrh | |
| Su et al. | Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator | |
| DE69839477D1 (de) | Verfahren zum verbessern der anhäufung von radioaktiven verbindungen in gewebe | |
| DK0827411T3 (da) | Fremgangsmåde til fastlæggelse af den optimale stråledosis til radiofamaceutisk sygdomsbehandling | |
| Anderson et al. | Antibodies labeled with 199Au: Potential of 199Au for radioimmunotherapy | |
| Kumar et al. | Lu-177-a noble tracer: future of personalized radionuclide therapy | |
| Saesow et al. | Diffusion and fate of intramuscularly injected human rabies immune globulin | |
| Mirzadeh et al. | Burn-up cross-section of 188W | |
| Vallabhajosula | Radiopharmaceuticals for therapy | |
| Zimmerman et al. | Enhancing Antibody: III. Site of Activity | |
| Matzku et al. | Antibody targeting to the murine lymphoma ESb‐MP: Increased accumulation due to reduced internauzation into lymphoma cells as compared to normal lymphoid cells | |
| Kwa et al. | Radioimmunotherapy of small-cell lung cancer xenografts using 131 I-labelled anti-NCAM monoclonal antibody 123C3 | |
| Harrington et al. | Recent developments in radioimmunotherapy | |
| Ang et al. | Effect of lithium and oral thyrotrophin-releasing hormone (TRH) on serum thyrotrophin (TSH) and radioiodine uptake in patients with well differentiated thyroid carcinoma | |
| Zamora et al. | Targeting peptides for pleural cavity tumor radiotherapy: specificity and dosimetry of Re-188-RC-160 | |
| Zanglis | The Ligand-The Receptor-The | |
| Slosman et al. | Use of radioactive ion beams for bio-medical research |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |